3629 results for «2277»
3629 results
LANDMARK RCT - Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial
15 May 2024 – From EuroPCR 2024
This session provides an overview of the early outcomes of the LANDMARK trial, a randomized non-inferiority trial comparing TAVI devices. It examines baseline characteristics, the significance of intermediate sizes according to MSCT recommendations, real-world representative cases from the LANDMARK RCT, insights from quantitative aortography and echocardiography...
The future of STEMI care: a new treatment for bridging the gap from diagnosis to treatment
14 May 2024 – From EuroPCR 2024
Watch this session to delve into the crucial role of pre-hospital STEMI diagnosis and treatment. Gain insights into the significance of early intervention and explore previous facilitated PCI trials in STEMI. Additionally, learn about a promising new agent for pre-hospital STEMI treatment, offering potential advancements in...
Planning for a lifetime starts with choosing the right valve first: from first TAVI to redo-TAVI
15 May 2024 – From EuroPCR 2024
Watch this session to learn the best practices for treating aortic stenosis, with a focus on lifetime management. Gain insights into evaluating patient anatomy and clinical presentation to anticipate the need for a second valve, understand different valve designs and their initial selection, and observe a...
A new horizon in IVUS-guided PCI of calcified stenoses with artificial intelligence
15 May 2024 – From EuroPCR 2024
In this session, observe the enhanced user-friendliness of IVUS-guided complex PCI with improved AI algorithms, recognize the importance of combining experience with advanced knowledge of tools and techniques for optimal PCI outcomes in heavily calcified stenoses, and understand how tailoring drug-eluting devices for calcified lesions can...
Restoring vessel physiology drives outcomes - The Bioadaptor experience
16 May 2024 – From EuroPCR 2024
Join this session to delve into the unmet needs concerning drug-eluting stents (DES), including poor long-term clinical outcomes, with up to a 50% MACE rate at 10 years, and a non-plateauing 2-3% annual event rate. Explore how DynamX Bioadaptor technology addresses these challenges by maintaining the...
How to make complex PCI safe, simple, and effective with new intracoronary and angiography imaging guidance
14 May 2024 – From EuroPCR 2024
Thanks to this session, learn how advanced imaging may guide and map complex PCI interventions, impacting on immediate results and clinical outcomes, by investigating which patients and lesions are complex, what are the practical issues to manage during PCI, and how modern AI-based high-resolution imaging can...
TAVI in TAVI - LIVE case
14 May 2024 – From EuroPCR 2024
A 74-year-old male with a history of cancer, TAVI with Evolut R 34 in 2019, COPD, obesity, and RBBB presents with a symptomatic degenerated valve (regurgitation).
It was decided to implant a Sapien 3 Ultra 26, without pre-dilatation and post-dilatation, using a temporary pacing lead (due to...
Cracking the calcium code - Novelty and utility of Hertz Contact intravascular lithotripsy
15 May 2024 – From EuroPCR 2024
Follow this session to learn about the novel HC-IVL system, its application for moderate to severe calcified lesions, and procedural tips. The LithiX Hertz Contact IVL addresses unmet needs in coronary artery calcification by offering a simplified workflow with fewer devices and effective treatment for difficult...
Why mechanical thrombectomy should be considered in the management of acute pulmonary embolism
16 May 2024 – From EuroPCR 2024
In this EuroPCR 2024 session, study the case of a patient with high-risk pulmonary embolism and another with intermediate to high-risk pulmonary embolism, delve into discussions on clinical evidence for mechanical thrombectomy in pulmonary embolism, acquire skills to evaluate eligibility for mechanical thrombectomy, and learn how to...
The turning point in hypertension care: Symplicity Spyral renal denervation in practice
15 May 2024 – From EuroPCR 2024
Explore this session to grasp the FDA-approved status of renal denervation, its safety and efficacy shown in numerous studies with lasting effects, and the importance of multidisciplinary discussions for successful indications. Consult also the session for updated recommendations on renal denervation in hypertension treatment guidelines, procedural safety...
Expanding the heart team - Improved TAVI outcomes through pre-and post-procedure collaboration
16 May 2024 – From EuroPCR 2024
In this session, learn how to advance heart team collaboration through optimized TAVI pre-work-up and refined severe aortic stenosis patient selection, ensuring accurate intervention indications. Gain hands-on insights for effective post-TAVI strategies, explore procedural and valve refinements that simplify post-TAVI PCI, and stay informed on the...
Innovations in TMVR and Intrepid trial updates
14 May 2024 – From EuroPCR 2024
Tune in to this session for comprehensive updates on APOLLO and Intrepid TF, along with invaluable lessons gleaned. Discover insights on patient screening for Intrepid TMVR, and delve into clinical case reviews highlighting advancements such as updated 29Fr access. Learn about the safety and efficacy of...
STEMI: thrombus is the problem
14 May 2024 – From EuroPCR 2024
This session will feature a series of selected clinical case submissions from EuroPCR 2024, focusing on the management of STEMI patients with a high thrombotic burden. Attendees will have the opportunity to explore various strategies and techniques, such as the use of pharmacomechanical thromboaspiration, prevention of...
Feedback from Innovator's Exchange Hub
13 May 2024 – From EuroPCR 2024
Innovations in renal denervation: deja vu or reality?
13 May 2024 – From EuroPCR 2024
Feedback from Innovator's Exchange Hub
13 May 2024 – From EuroPCR 2024
Innovations in heart failure: moving the heart forward
13 May 2024 – From EuroPCR 2024
Is this patient a good candidate for Left Atrial Appendage Closure? An interactive rapid-fire discussion
16 May 2024 – From EuroPCR 2024
This interactive session focuses on selecting good candidates for left atrial appendage (LAA) closure procedures. It covers the key clinical elements driving the indication for LAA closure and the technical elements that make a case complex. Through a series of case presentations and discussions, the session...
Randomised trials: substudies and extended follow-up - A quick update
15 May 2024 – From EuroPCR 2024
This session provides a quick update on various randomised trials, including substudies and extended follow-up data. It covers insights on bifurcation stenting, the symptom-stratified analysis of ORBITA-2, the impact of completeness of revascularisation on clinical outcomes from REVIVED-BCIS2, cost-effectiveness of CABG vs. PCI from FAME 3,...
Jon DeHaan Foundation Award ceremony
14 May 2024 – From EuroPCR 2024
This session is the Jon DeHaan Foundation Award ceremony, recognizing and celebrating outstanding achievements in the field of interventional cardiology.
